ATE365227T1 - Endometriose marker und verwendung derselben - Google Patents

Endometriose marker und verwendung derselben

Info

Publication number
ATE365227T1
ATE365227T1 AT01909382T AT01909382T ATE365227T1 AT E365227 T1 ATE365227 T1 AT E365227T1 AT 01909382 T AT01909382 T AT 01909382T AT 01909382 T AT01909382 T AT 01909382T AT E365227 T1 ATE365227 T1 AT E365227T1
Authority
AT
Austria
Prior art keywords
endometriosis
methods
females
much less
relates
Prior art date
Application number
AT01909382T
Other languages
English (en)
Inventor
Soheyl Baban
Monique Bernard
Elana Cherry
Diane Gosselin
Patrice Hugo
Brigitte Malette
Pierre Miron
Charles Prive
Kamran Shazand
Original Assignee
Diagnostic Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostic Products Corp filed Critical Diagnostic Products Corp
Application granted granted Critical
Publication of ATE365227T1 publication Critical patent/ATE365227T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AT01909382T 2000-02-25 2001-02-26 Endometriose marker und verwendung derselben ATE365227T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18506300P 2000-02-25 2000-02-25
US22574500P 2000-08-17 2000-08-17

Publications (1)

Publication Number Publication Date
ATE365227T1 true ATE365227T1 (de) 2007-07-15

Family

ID=26880752

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01909382T ATE365227T1 (de) 2000-02-25 2001-02-26 Endometriose marker und verwendung derselben

Country Status (10)

Country Link
US (3) US6777182B2 (de)
EP (1) EP1290218B8 (de)
JP (1) JP2003531580A (de)
AT (1) ATE365227T1 (de)
AU (1) AU2001237178A1 (de)
BR (1) BR0108685A (de)
CA (1) CA2399259A1 (de)
DE (2) DE60129018T2 (de)
ES (2) ES2336817T3 (de)
WO (1) WO2001062959A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100414637B1 (ko) * 2000-02-08 2004-01-13 (주)에스제이바이오메드 사람 미토콘드리아 아데닐레이트 키나제 이소자임들에대한 항체와 면역학적 제제 및 심장질환 진단키트
US6884578B2 (en) * 2000-03-31 2005-04-26 Affymetrix, Inc. Genes differentially expressed in secretory versus proliferative endometrium
EP1511863A4 (de) * 2002-05-14 2006-12-27 Univ Leland Stanford Junior Endometriale gene bei erkrankungen des endometriums
US20050214836A1 (en) * 2002-08-30 2005-09-29 Oncotherapy Science, Inc. Method of diagnosing ovarian endometriosis
WO2005008251A2 (en) 2003-07-11 2005-01-27 Praecis Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
WO2005008247A2 (en) * 2003-07-11 2005-01-27 Science & Technology Corporation @ Unm. Detection of endometrial pathology
AU2004303448A1 (en) * 2003-12-23 2005-07-07 Mount Sinai Hospital Methods for detecting markers associated with endometrial disease or phase
EP1730183A2 (de) * 2004-01-27 2006-12-13 Compugen USA, Inc. Neue nukleotid- und aminosäuresequenzen sowie tests und verfahren dafür zur diagnose von endometriose
US20060008876A1 (en) * 2004-07-07 2006-01-12 Shami A S E ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
US7943324B2 (en) * 2004-12-22 2011-05-17 The Trustees Of The University Of Pennsylvania Endometriosis markers
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
BRPI0613042A2 (pt) * 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
US8338111B2 (en) * 2006-12-22 2012-12-25 The Trustees Of The University Of Pennsylvania Endometriosis markers
US20080305967A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Genetic Markers Associated with Endometriosis and Use Thereof
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
CA2715080C (en) 2007-09-28 2021-09-28 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
RU2011140471A (ru) 2009-03-06 2013-04-20 Мотида Фармасьютикал Ко., Лтд. Способ диагностики эндометриоза и диагностический набор для эндометриоза
WO2010107734A2 (en) * 2009-03-16 2010-09-23 Ozgul Muneyyirci-Delale Methods for detecting endometriosis
WO2010124101A2 (en) * 2009-04-22 2010-10-28 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
GB201012662D0 (en) * 2010-07-28 2010-09-15 Valirx Plc Method for detecting the presence of a gynaecological growth
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
GB201302837D0 (en) * 2013-02-19 2013-04-03 Univ Singapore Therapeutic Agents
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
KR20170063519A (ko) * 2014-07-17 2017-06-08 셀매틱스, 인크. 불임 및 관련 병리상태를 평가하기 위한 방법 및 시스템
EP3436580B1 (de) 2016-03-30 2021-03-17 Life Technologies AS Verbesserte verfahren und zusammensetzungen für nukleinsäureisolierung
WO2017201748A1 (zh) * 2016-05-27 2017-11-30 曾启瑞 一种检测子宫内膜异位症之方法与其应用
WO2019115829A1 (en) * 2017-12-15 2019-06-20 Endodiag Pépinière Génopole Entreprises Method of diagnosing endometriosis
CA3097421A1 (en) * 2018-04-20 2019-10-24 Nameer KIRMA Compositions and methods for treating endometriosis
JP7191361B2 (ja) * 2018-08-13 2022-12-19 学校法人 埼玉医科大学 産婦人科疾患の罹患可能性の判定を補助するための方法、産婦人科疾患の罹患可能性を診断するためのデータを収集する方法、及び産婦人科疾患の診断用キット
KR102255691B1 (ko) * 2018-12-14 2021-05-26 대한민국 돼지 발정주기 탐지용 자궁내막 유전자 및 그의 용도
US20220221472A1 (en) * 2019-04-26 2022-07-14 Chugai Seiyaku Kabushiki Kaisha Method for diagnosing endometriosis, disease state monitoring method, and kit

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478725A (en) * 1992-06-12 1995-12-26 University Of Pennsylvania αv β3 integrin as a predictor of endometriosis
DE19824230A1 (de) * 1998-05-29 1999-12-02 Starzinski Powitz Anna Neues Endometriose-assoziiertes Gen
AU765750B2 (en) * 1998-06-04 2003-09-25 Reprogen, Inc. Use of cathepsin s in the diagnosis and treatment of endometriosis
AU760613B2 (en) * 1998-06-04 2003-05-22 Reprogen, Inc. Use of prothymosin in the diagnosis and treatment of endometriosis
JP4804692B2 (ja) * 2000-02-24 2011-11-02 東京エレクトロン株式会社 ガス漏洩検知システム、ガス漏洩検知方法及び半導体製造装置

Also Published As

Publication number Publication date
EP1290218B1 (de) 2007-06-20
WO2001062959A2 (en) 2001-08-30
EP1290218B8 (de) 2007-10-03
EP1290218A2 (de) 2003-03-12
US20120208869A1 (en) 2012-08-16
ES2336817T3 (es) 2010-04-16
DE60129018T2 (de) 2008-02-21
CA2399259A1 (en) 2001-08-30
JP2003531580A (ja) 2003-10-28
US20020127555A1 (en) 2002-09-12
AU2001237178A1 (en) 2001-09-03
US8148061B2 (en) 2012-04-03
ES2287100T3 (es) 2007-12-16
US20060057584A1 (en) 2006-03-16
US6777182B2 (en) 2004-08-17
US8541173B2 (en) 2013-09-24
WO2001062959A3 (en) 2003-01-03
DE60129018D1 (de) 2007-08-02
DE60140580D1 (de) 2009-12-31
BR0108685A (pt) 2003-12-30

Similar Documents

Publication Publication Date Title
ATE365227T1 (de) Endometriose marker und verwendung derselben
ES2568900T3 (es) Ensayo para la metilación en el gen para la GST-Pi
WO2005005601A8 (en) Compositions and methods for treating and diagnosing cancer
BR9814271A (pt) Determinação de doenças relacionadas com o vìrus do papiloma humano
WO2002086448A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
WO2002044418A3 (en) Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
WO2002022879A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
Wei et al. Discovery and validation of hypermethylated markers for colorectal cancer
DK1631686T3 (da) Påvisning af dysplasi i høj grad i cervicale celler
Kawaguchi et al. Genetic and epigenetic alterations of the PTEN gene in soft tissue sarcomas
ATE350662T1 (de) Markerproteine für prostatakrebs
DE60239059D1 (de) Verfahren und zusammensetzungen zur hemmung, prävention oder verringerung des tumorzellwachstums beingen einer antiöstrogen-therapie resistent sind
ATE199025T1 (de) Test zur diagnose eines erhöhten brustkrebs- risikos
WO2001042792A3 (en) Diagnosis of cervical cancer using marker proteins
ATE366936T1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
WO2003068268A3 (en) Treatment, diagnosis and imaging of disease
SE9900615D0 (sv) Method and kit for early cancer prediction
EP1801236A3 (de) Endometriose Marker und Verwendung derselben
Calistri et al. Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer
DE69937895D1 (de) Pyrano, piperidino, und thiopyrano derivate und methode zur verwendung
WO2001004343A3 (en) A method for determining the prognosis of cancer patients by measuring levels of bag expression
WO2002044417A3 (en) Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
ES2336451T3 (es) Metodo para evaluar un estado canceroso.
EA200600012A1 (ru) Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку
Arisan The importance of molecular tumor markers for bladder cancer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties